$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Sulfamoylbenzamide-based Capsid Assembly Modulators for Selective Inhibition of Hepatitis B Viral Replication 원문보기

ACS medicinal chemistry letters, v.12 no.2, 2021년, pp.242 - 248  

Lee, Yeon Hee (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) ,  Cha, Hyeon-Min (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) ,  Hwang, Jun Yeon (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) ,  Park, So Yeong (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) ,  Vishakantegowda, Avinash G. (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) ,  Imran, Ali (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) ,  Lee, Joo-Youn (Therapeutics & B) ,  Yi, Yoon-Sun ,  Jun, Sangmi ,  Kim, Ga Hyeon ,  Kang, Hyo Jin ,  Chung, Sang J. ,  Kim, Meehyein ,  Kim, Hyejin ,  Han, Soo Bong

Abstract AI-Helper 아이콘AI-Helper

As the spread of infections caused by hepatitis B virus (HBV) threatens public health worldwide, investigations from multiple perspectives and of various mechanisms of action are urgently required to increase the HBV cure rate. Targeting the encapsidation of the nuclear capsid protein (core protein,...

Keyword

참고문헌 (24)

  1. World Health Organization Hepatitis B fact sheet, 2020. https://www.who.int/news-room/fact-sheets/detail/hepatitis-B (accessed July 10, 2020). 

  2. Yuen, Man‐Fung, Lai, Ching‐Lung. Treatment of chronic hepatitis B: Evolution over two decades. Journal of gastroenterology and hepatology, vol.26, no.suppl.s1, 138-143.

  3. Fung, J., Lai, C.-L., Seto, W.-K., Yuen, M.-F.. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. The Journal of antimicrobial chemotherapy, vol.66, no.12, 2715-2725.

  4. Craxi, Antonio, Cooksley, W.Graham. Pegylated interferons for chronic hepatitis B. Antiviral research, vol.60, no.2, 87-89.

  5. Shaw, Tim, Bartholomeusz, Angeline, Locarnini, Stephen. HBV drug resistance: Mechanisms, detection and interpretation. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.44, no.3, 593-606.

  6. Zoulim, Fabien, Locarnini, Stephen. Hepatitis B Virus Resistance to Nucleos(t)ide Analogues. Gastroenterology, vol.137, no.5, 1593-1608.e2.

  7. Nassal, Michael. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut: journal of the British Society of Gastroenterology, vol.64, no.12, 1972-1984.

  8. Allweiss, Lena, Dandri, Maura. The Role of cccDNA in HBV Maintenance. Viruses, vol.9, no.6, 156-.

  9. Zhu, Anjing, Liao, Xinzhong, Li, Shuang, Zhao, Hang, Chen, Limin, Xu, Min, Duan, Xiaoqiong. HBV cccDNA and Its Potential as a Therapeutic Target. Journal of clinical and translational hepatology, vol.7, no.3, 1-5.

  10. Ligat, Gaëtan, Goto, Kaku, Verrier, Eloi, Baumert, Thomas F.. Targeting Viral cccDNA for Cure of Chronic Hepatitis B. Current Hepatology Reports, vol.19, no.3, 235-244.

  11. Liang, T. Jake, Block, Timothy M., McMahon, Brian J., Ghany, Marc G., Urban, Stephan, Guo, Ju‐Tao, Locarnini, Stephen, Zoulim, Fabien, Chang, Kyong‐Mi, Lok, Anna S.. Present and future therapies of hepatitis B: From discovery to cure. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.62, no.6, 1893-1908.

  12. Dawood, Altaf, Abdul Basit, Syed, Jayaraj, Mahendran, Gish, Robert G.. Drugs in Development for Hepatitis B. Drugs, vol.77, no.12, 1263-1280.

  13. Lopatin, Uri. Drugs in the Pipeline for HBV. Clinics in liver disease, vol.23, no.3, 535-555.

  14. Zlotnick, A., Venkatakrishnan, B., Tan, Z., Lewellyn, E., Turner, W., Francis, S.. Core protein: A pleiotropic keystone in the HBV lifecycle. Antiviral research, vol.121, 82-93.

  15. Diab, Ahmed, Foca, Adrien, Zoulim, Fabien, Durantel, David, Andrisani, Ourania. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals. Antiviral research, vol.149, 211-220.

  16. Feng, Song, Gao, Lu, Han, Xingchun, Hu, Taishan, Hu, Yimin, Liu, Haixia, Thomas, Andrew W., Yan, Zhipeng, Yang, Song, Young, John A. T., Yun, Hongying, Zhu, Wei, Shen, Hong C.. Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection. ACS infectious diseases, vol.4, no.3, 257-277.

  17. Yang, Li, Liu, Feifei, Tong, Xiankun, Hoffmann, Daniel, Zuo, Jianping, Lu, Mengji. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives. ACS infectious diseases, vol.5, no.5, 713-724.

  18. Nijampatnam, Bhavitavya, Liotta, Dennis C. Recent advances in the development of HBV capsid assembly modulators. Current opinion in chemical biology, vol.50, 73-79.

  19. Deres, Karl, Schröder, Claus H., Paessens, Arnold, Goldmann, Siegfried, Hacker, Hans Jörg, Weber, Olaf, Krämer, Thomas, Niewöhner, Ulrich, Pleiss, Ulrich, Stoltefuss, Jürgen, Graef, Erwin, Koletzki, Diana, Masantschek, Ralf N. A., Reimann, Anja, Jaeger, Rainer, Groß, Rainer, Beckermann, Bernhard, Schlemmer, Karl-Heinz, Haebich, Dieter, Rübsamen-Waigmann, Helga. Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids. Science, vol.299, no.5608, 893-896.

  20. Delaney IV, William E., Edwards, Ros, Colledge, Danni, Shaw, Tim, Furman, Phil, Painter, George, Locarnini, Stephen. Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro. Antimicrobial agents and chemotherapy, vol.46, no.9, 3057-3060.

  21. Hepatology Gane E. 1279A 60 2014 

  22. Na, Hyo Gyeong, Imran, Ali, Kim, Kyuneun, Han, Hong Sik, Lee, Young Jin, Kim, Myung-Jin, Yun, Chang-Soo, Jung, Young-Sik, Lee, Joo-Youn, Han, Soo Bong. Discovery of a New Sulfonamide Hepatitis B Capsid Assembly Modulator. ACS medicinal chemistry letters, vol.11, no.2, 166-171.

  23. Zhou, Zheng, Hu, Taishan, Zhou, Xue, Wildum, Steffen, Garcia-Alcalde, Fernando, Xu, Zhiheng, Wu, Daitze, Mao, Yi, Tian, Xiaojun, Zhou, Yuan, Shen, Fang, Zhang, Zhisen, Tang, Guozhi, Najera, Isabel, Yang, Guang, Shen, Hong C., Young, John A. T., Qin, Ning. Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. Scientific reports, vol.7, 42374-.

  24. Liu, Chuang, Fan, Guizhen, Wang, Zhao, Chen, Hong-Song, Yin, Chang-Cheng. Allosteric conformational changes of human HBV core protein transform its assembly. Scientific reports, vol.7, 1404-1404.

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로